US OptionsDetailed Quotes
LYRA240719P7500
- 1.92
- 0.000.00%
15min DelayClose Jul 5 16:00 ET
0.00High0.00Low
1.92Open1.92Pre Close0 Volume5 Open Interest7.50Strike Price0.00Turnover0.00%IV-1951.47%PremiumJul 19, 2024Expiry Date7.23Intrinsic Value100Multiplier14DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.04Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Lyra Therapeutics Stock Discussion
Sign in to post a comment
$Lyra Therapeutics(LYRA.US$
The recent developments reported in Lyra Therapeutics’ latest 8-K filing present a mixed picture for investors:
Positive Aspects:
1. Cost Reduction: The workforce reduction is aimed at cutting operating expenses, which could improve the company’s financial health and increase shareholder value in the long run. This move shows the company’s proactive approach to managing costs and resources efficiently.
2. Retention of Key Executives: The approv...
The recent developments reported in Lyra Therapeutics’ latest 8-K filing present a mixed picture for investors:
Positive Aspects:
1. Cost Reduction: The workforce reduction is aimed at cutting operating expenses, which could improve the company’s financial health and increase shareholder value in the long run. This move shows the company’s proactive approach to managing costs and resources efficiently.
2. Retention of Key Executives: The approv...
5
1
$Lyra Therapeutics(LYRA.US$ .. go to de-listed?
2
1
$Lyra Therapeutics(LYRA.US$ will this ever come back?
1
2
$Lyra Therapeutics(LYRA.US$ the risk reward ...only for short term
$Lyra Therapeutics(LYRA.US$
Based on the charts and market data:
• The significant increase in short volume and short interest indicates a potential short squeeze.
• The support level is at $3.060, and the resistance is at $7.040.
• The current price action shows strong upward momentum.
Note: This analysis suggests potential for a short squeeze, but always consider the risks and do your own research before making any investment decisions. This i...
Based on the charts and market data:
• The significant increase in short volume and short interest indicates a potential short squeeze.
• The support level is at $3.060, and the resistance is at $7.040.
• The current price action shows strong upward momentum.
Note: This analysis suggests potential for a short squeeze, but always consider the risks and do your own research before making any investment decisions. This i...
6
1
$Lyra Therapeutics(LYRA.US$ $80 millions cash or cash equivalent ...
I was waiting to begin hearing people talk negative about this company and since we've reached that point, I'm making a large entry
2
$Lyra Therapeutics(LYRA.US$ This company is game over
1
$Lyra Therapeutics(LYRA.US$ remember buy .34 cents this will going up $.43 cents 😁😄😁👍
1
1
No comment yet
还是算了 : The most important thing for pharmaceutical companies is research and development. If there are no plans for R&D now, it is chronic death